| Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites V Forster, RD Signorell, M Roveri, JC Leroux Science translational medicine 6 (258), 258ra141-258ra141, 2014 | 76 | 2014 |
| Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes V Forster, P Luciani, JC Leroux Biomaterials 33 (13), 3578-3585, 2012 | 37 | 2012 |
| 3D strain map of axially loaded mouse tibia: a numerical analysis validated by experimental measurements VA Stadelmann, J Hocké, J Verhelle, V Forster, F Merlini, A Terrier, ... Computer methods in biomechanics and biomedical engineering 12 (1), 95-100, 2009 | 36 | 2009 |
| Nano-antidotes for drug overdose and poisoning V Forster, JC Leroux Science translational medicine 7 (290), 290ps14-290ps14, 2015 | 30 | 2015 |
| Liposome‐supported peritoneal dialysis for the treatment of hyperammonemia‐associated encephalopathy V Agostoni, SH Lee, V Forster, M Kabbaj, CR Bosoi, M Tremblay, ... Advanced functional materials 26 (46), 8382-8389, 2016 | 27 | 2016 |
| Liposome-supported peritoneal dialysis in the treatment of severe hyperammonemia: An investigation on potential interactions G Giacalone, S Matoori, V Agostoni, V Forster, M Kabbaj, ... Journal of controlled release 278, 57-65, 2018 | 20 | 2018 |
| Liposome-supported enzymatic peritoneal dialysis A Pratsinis, S Zuercher, V Forster, EJ Fischer, P Luciani, JC Leroux Biomaterials 145, 128-137, 2017 | 19 | 2017 |
| Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises S Matoori, V Forster, V Agostoni, R Bettschart-Wolfensberger, RN Bektas, ... Journal of Controlled Release 328, 503-513, 2020 | 8 | 2020 |
| Liposome composition for use in peritoneal dialysis JC Leroux, V Forster US Patent 10,596,114, 2020 | 3 | 2020 |
| SuO015 VS-01-A PROMISING INTRAPERITONEAL TREATMENT TO MANAGE HEPATIC ENCEPHALOPATHY AND RENAL FAILURE IN CIRRHOTIC PATIENTS V Forster, V Agostoni, G Giacalone, S Lee, M Kabbaj, C Bosoi, ... Nephrology Dialysis Transplantation 33 (suppl_1), i622-i622, 2018 | 1 | 2018 |
| Injectable nano-antidotes (Nanotidotes) for the treatment of drug overdose and poisoning V Forster, JC Leroux | 1 | 2015 |
| Drug-scavenging liposomes attenuate the cardiovascular toxicity of overdosed calcium channel blockers V Forster, P Luciani, J Leroux Biomaterials 33 (13), 3578-3585, 2012 | 1 | 2012 |
| Design of a multi-scale canine-specific model of cardiac electromechanics: a step toward patient-specific modeling V Forster | 1 | 2008 |
| Method for Preparing Transmembrane pH-Gradient Vesicles JC Leroux, V Forster, V Agostoni US Patent App. 17/831,071, 2022 | | 2022 |
| Method for preparing transmembrane pH-gradient vesicles JC Leroux, V Forster, V Agostoni US Patent 11,376,218, 2022 | | 2022 |
| Liposome composition for use in peritoneal dialysis JC Leroux, V Forster US Patent App. 17/018,438, 2021 | | 2021 |
| Liposome composition for use in peritoneal dialysis JC Leroux, V Forster US Patent App. 16/165,202, 2019 | | 2019 |
| VS-01-A PROMISING INTRAPERITONEAL TREATMENT TO MANAGE HEPATIC ENCEPHALOPATHY AND RENAL FAILURE IN CIRRHOTIC PATIENTS V Forster, V Agostoni, G Giacalone, S Lee, M Kabbaj, C Bosoi, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 33, 1622-1622, 2018 | | 2018 |
| Drugs Interactions and Metabolomic Profile During Liposome-Supported Peritoneal Dialysis (LSPD) in the Treatment of Severe Hyperammonemia G Giacalone, V Forster, V Agostoni, M Kabbaj, N Zamboni, JC Leroux Journal of Clinical and Experimental Hepatology 7, S15, 2017 | | 2017 |
| Hyperammonemia: Liposome‐Supported Peritoneal Dialysis for the Treatment of Hyperammonemia‐Associated Encephalopathy (Adv. Funct. Mater. 46/2016) V Agostoni, SH Lee, V Forster, M Kabbaj, CR Bosoi, M Tremblay, ... Advanced Functional Materials 26 (46), 8357-8357, 2016 | | 2016 |
